Hematopoietic stem cell transplantation and quality of life during the first year of treatment.

Angela da Costa Barcellos MarquesAna Paula SzczepanikCelina Angélica Mattos MachadoPâmella Naiana Dias SantosPaulo Ricardo Bittencourt GuimarãesLuciana Puchalski Kalinke

Published in: Revista latino-americana de enfermagem (2018)

although the aggressiveness of treatment affects quality of life, patients consider it satisfactory after the first year. There are few significant differences between autologous and allogenic patients, and both groups have recovered in the course of the process.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
bone marrow
combination therapy
patient reported